Thank you.
I want to pick up on the idea of patents. We've heard that the Biden administration has finally come on board. It looks like they're going to be supporting a TRIPS waiver, a waiver on patents internationally. I'm wondering what considerations your advisory group had on the possibility of patent waivers. How did you account for that in your potential planning in terms of market availability and supply curves?